BKV — BKV CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying BKV?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their BKV position last quarter, 3 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime).
- +3 tracked investors added or increased positions last quarter (David Einhorn, Izzy Englander, Ken Griffin)
- +3 tracked investors reported holding BKV at their latest filing
- +Macro Health is 55/100 in a Squeeze regime — historically acceptable for this sectorsource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/20/2026.
About BKV CORP (BKV)
BKV CORP (BKV) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by David Einhorn (DME Capital Management, LP), valued at $85M. Across recent filings, tracked investors recorded 6 new positions, 6 increased, 4 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BKV
How many top investors track BKV
A small number of top investors own this.
BKV Ownership Composition
How BKV CORP is held across tracked investor types, based on reported 13F positions.
- Value & Distressed62.8%
- Multi-Strategy / Quant37.2%
Tracked investors currently reporting BKV
2 tracked investors have since exited this position — listed separately below.
- David EinhornJun 30, 2026DME Capital Management, LPShares3.1MValue$84.7M% Portfolio2.17%
- Ken GriffinJun 30, 2026Citadel AdvisorsShares1.8MValue$49.3M% Portfolio0.01%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares36.3KValue$992.9K% Portfolio0.00%
Previously held BKV
These investors reported BKV in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Paul Tudor Jones | Tudor Investment Corp | 53.9K | $1.3M | Jun 30, 2025 |
| Steve Cohen | Point72 Asset Management | 49.9K | $912K | Sep 30, 2024 |
Recent activity
- $35MFeb 17, 2026
- Increased$76.9M(109.29%)May 15, 2026
- Increased$84.7M(14.83%)Aug 14, 2026
- $15.2MNov 14, 2024
- Reduced$16.7M(-15.37%)Feb 14, 2025
- Reduced$12.6M(-15.01%)May 15, 2025
- Increased$22.8M(58.16%)Aug 14, 2025
- Reduced$518.7K(-48.56%)Feb 17, 2026
- Reduced$357K(-34.48%)May 15, 2026
- Increased$992.9K(189.90%)Aug 14, 2026
- New$9.6MNov 14, 2024
- New$3.9MMay 15, 2025
- Sold$0(-100.00%)Aug 14, 2025
- Increased$49.3M(254.41%)Aug 14, 2026
- New$912KNov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- $975.5KMay 15, 2025
- Increased$1.3M(16.03%)Aug 14, 2025
- Sold$0(-100.00%)Dec 9, 2025
Frequently asked questions
- How many institutional investors hold BKV?
- 3 tracked institutional investors disclosed a position in BKV (BKV CORP) in their most recent 13F filing.
- Who is the largest institutional holder of BKV?
- David Einhorn, DME Capital Management, LP, holds the largest disclosed position in BKV, valued at $85M.
- Did institutional ownership of BKV increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 6 increased, 4 reduced, and 3 fully exited BKV.
- Where does this BKV ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.